Literature DB >> 32460981

Atypical CML- the role of morphology and precision genomics.

Terra Lasho1.   

Abstract

Atypical chronic myeloid leukemia is an esoteric myeloid malignancy with features of both myeloproliferative and myelodysplastic syndromes. This disease is characterized primarily by morphologic-based criteria, and has clinical and molecular features overlapping with other myeloid malignancies. No one molecular abnormality is specific, and multiple mutations are often present in various combinations, due to the malignant multi-step clonal evolution of myeloid malignancies. In this review, we will address what we know about atypical chronic myeloid leukemia; evaluate how the molecular landscape in myeloid malignancies overlaps, and discuss what we can learn by incorporating individualized precision genomic strategies.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Atypical chronic myeloid leukemia; Clonal evolution; Clonal expansion; Dysplastic granulopoiesis; Precision genomics

Mesh:

Year:  2019        PMID: 32460981     DOI: 10.1016/j.beha.2019.101133

Source DB:  PubMed          Journal:  Best Pract Res Clin Haematol        ISSN: 1521-6926            Impact factor:   3.020


  2 in total

1.  Trametinib: Could It Be a Promising Drug to Treat Atypical Chronic Myeloid Leukemia?

Authors:  Marwa Elsayed; Stephanie Harry; Suprana Nanua; Shayaan Zaidi; Muhammad H Habib; Shahzad Raza
Journal:  Cureus       Date:  2022-07-06

Review 2.  Atypical Chronic Myeloid Leukemia: Where Are We Now?

Authors:  Elena Crisà; Maura Nicolosi; Valentina Ferri; Chiara Favini; Gianluca Gaidano; Andrea Patriarca
Journal:  Int J Mol Sci       Date:  2020-09-18       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.